Defining the contractile prostanoid component in hyperosmolar-induced bronchoconstriction in human small airways

Area of Science:

• Pulmonary Medicine
• Respiratory Physiology
• Pharmacology

Background:

• Exercise-induced bronchoconstriction (EIB) is a common condition in athletes.
• Increased airway osmolarity during exercise is a primary trigger for EIB.
• The specific prostanoid mediators involved in EIB require further elucidation.

Purpose of the Study:

• To identify the contractile prostanoid component of exercise-induced bronchoconstriction (EIB).
• To investigate the role of specific prostanoids and their synthetic pathways in EIB using an ex vivo human airway model.

Main Methods:

• Utilized an ex vivo model with intact human bronchial segments (0.5-2 mm inner diameter).
• Exposed bronchial segments to hyperosmolar mannitol to simulate exercise-induced osmotic stress.
• Assessed airway contraction and the effects of mast cell elimination and various receptor antagonists/enzyme inhibitors.

Main Results:

• Hyperosmolar mannitol induced significant bronchial contraction (64.3%).
• Contraction was abrogated by mast cell elimination or combined antagonists for cysteinyl leukotriene (cysLT1), histamine (H1), and thromboxane (TP) receptors.
• TP receptor antagonism, replaced by inhibition of cyclooxygenase-1 (COX-1), prostaglandin D synthase (PGD synthase), or TXA synthase, also prevented contraction.
• These findings implicate prostaglandin D2 (PGD2) and thromboxane A2 (TXA2) generated via COX-1 and their respective synthases in the TP-mediated component of EIB.

Conclusions:

• The prostanoid pathway, specifically involving prostaglandin D2 and thromboxane A2 acting via the thromboxane receptor, is a critical component of exercise-induced bronchoconstriction.
• Mast cells and other inflammatory mediators like cysteinyl leukotrienes and histamine also contribute to EIB.
• This study provides insights into the pharmacological targets for managing EIB.